Investigating how to alter the sex ratio of Aedes aegypti mosquitoes
Sex ratio distortion in Aedes aegypti
This study is looking at ways to reduce the number of disease-carrying female mosquitoes by using genetic techniques to create more male mosquitoes, which could help lower the spread of illnesses like dengue and chikungunya.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Polytechnic Inst and St Univ NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-10898856 on NIH RePORTER |
What this research studies
This research focuses on Aedes aegypti mosquitoes, which are known carriers of diseases like dengue and chikungunya. The project aims to develop genetic strategies to control mosquito populations by creating a male-biased sex ratio, thereby reducing the number of females that can transmit diseases. Using advanced techniques like CRISPR, the researchers will explore how to manipulate the genetic factors that determine the sex of these mosquitoes. This innovative approach seeks to provide a sustainable solution to combat the rising incidence of mosquito-borne diseases.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals living in regions heavily affected by mosquito-borne diseases.
Not a fit: Patients who live in areas where Aedes aegypti mosquitoes are not prevalent may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the transmission of diseases like dengue and chikungunya by lowering the population of disease-carrying female mosquitoes.
How similar studies have performed: Previous research has shown promising results with genetic strategies for mosquito control, indicating that this approach could be effective.
Where this research is happening
Blacksburg, United States
- Virginia Polytechnic Inst and St Univ — Blacksburg, United States (Active)
Researchers
- Principal investigator: Tu, Zhijian Jake — Virginia Polytechnic Inst and St Univ
- Study coordinator: Tu, Zhijian Jake
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.